Ullman Cited in Article on Alleged Disease Claims

November 11, 2021 | Compliance Investigations & White Collar

Marc Ullman was cited in the NutraIngredientsUSA.com article, “FDA takes Quicksilver Scientific to task over alleged disease claims in blog post.”

The article examines how narrow the margin between acceptable language and an alleged disease claim can be. Dietary supplement manufacturer, Quicksilver Scientific, made a number of alleged disease claims in blog posts that earned the company an FDA warning letter.

“Talking about the effects of ingredients, even when those effects might be well supported by scientific evidence, is as much art as it is science,” Ullman stated.

Read the full article here.

Share this article:

Related News

Get legal updates and news delivered to your inbox